{
  "nct_id": "NCT48703275",
  "indication": "Rheumatoid Arthritis",
  "phase": "Phase 1",
  "sample_size": 71,
  "duration_weeks": 23,
  "dropout_rate": 0.09,
  "blinding": "open-label",
  "control_arm": "standard of care",
  "primary_endpoints": [
    "ACR20 response"
  ],
  "secondary_endpoints": [
    "HAQ-DI improvement"
  ],
  "outcome_summary": "Statistically significant clinical benefit observed",
  "success": 1,
  "start_date": "2019-12-27",
  "completion_date": "2020-06-05"
}